Endogenex
MN - PlymouthMedical Devices
Focus: Endogenex is a medical device company specializing in pulsed electric field catheters for metabolic disease treatment, specifically Type 2 Diabetes management. The company went public in 2010 and operates from Plymouth, Minnesota with a focused, single-indication product portfolio.
Profile data last refreshed 2d ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Endogenex
AI assessmentNot HiringNo open roles listed right now. Follow Endogenex to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
6 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Endogenex System / ReCET Treatment
Stable
Growth
Core marketed device platform with post-market surveillance registry active; appears to be company's lead commercial product.
Pipeline & Clinical Trials
Help build intelligence for Endogenex
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.